{"disease":{"id":"autoimmune-inner-ear-disease","name":"autoimmune inner ear disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04806282","title":"Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets","phase":"","overall_status":"SUSPENDED","enrollment_count":58,"lead_sponsor_name":"National Institute on Deafness and Other Communication Disorders (NIDCD)","has_results":false},{"nct_id":"NCT03587701","title":"Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":57,"lead_sponsor_name":"Northwell Health","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}